Home / Companies / Ligand Pharmaceuticals Incorporated / 14 Jun 2024
Ligand Pharmaceuticals Incorporated: meeting of 14 Jun 2024
Votes reported on Form N-PX, item by item
406 Form N-PX filers reported votes at the Ligand Pharmaceuticals Incorporated meeting of 14 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
8 nominees; 94.5% of reported votes for; 32 filers withheld from or voted against at least one nominee.
2,326 vote records from 143 filers. 2 of the 143 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
629 vote records from 400 filers. 46 of the 391 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
291 vote records from 141 filers. 2 of the 141 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
298 vote records from 145 filers. 80 of the 145 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Ligand Pharmaceuticals Incorporated meeting?
406 Form N-PX filers reported votes at the meeting of 14 Jun 2024. On say-on-pay, 46 of 391 voted against management (11.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ligand Pharmaceuticals Incorporated on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Ligand Pharmaceuticals Incorporated
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ligand Pharmaceuticals Incorporated with a meeting date within three days of 14 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.